NCT07015970

Brief Summary

This is a non-interventional, prospective, multi-site study conducted in France among adults with type 1 diabetes mellitus using automated insulin delivery (AID) systems and engaging in at least two exercise sessions per week, each lasting at least 30 minutes. The main objective of this study is to describe the glycemic control of athletic participants with type 1 diabetes mellitus who use an insulin pump with AID and engage in physical exercise under real-life conditions. Two physician data collection time points are planned: the first occurs at baseline and includes demographic and clinical data, glycemic control during the month preceding inclusion, diabetes management, and information on usual physical exercise (duration, type, sport practiced, competition participation, and adherence to a specific diet). The second occurs at 1-month follow-up and involves downloading insulin pump and glucose sensor data, covering the period from 15 days before the first reported exercise session to 15 days after the last session. During the 1-month study period, participants will complete a paper logbook after each exercise session to document information such as the type of exercise, self-reported intensity using the modified Borg scale and the WHO physical activity intensity scale, duration, system adjustments, dietary intake, occurrence of hypoglycemia and associated symptoms, snacks consumed, and treatments administered for hypoglycemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
Last Updated

January 26, 2026

Status Verified

May 1, 2025

Enrollment Period

10 months

First QC Date

May 23, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

Automated insulin deliveryExerciceDiabetes Mellitus, Type 1HypoglycemiaGlycemic control

Outcome Measures

Primary Outcomes (1)

  • Time Below Range

    Percentage of time spent with glucose \<70 mg/dL and \<54 mg/dL before the exercise (within 2 hours prior), during exercise, during early recovery (within 3 hours after exercise), late recovery (from 3 hours after exercise to 8:00 a.m. the following day or until the next pre-exercise window, if closely), and during non-exercise periods

    One month

Secondary Outcomes (6)

  • Time-in-Range

    One month

  • Time Above Range

    One month

  • Ajustement Practices

    One month

  • ADDQoL questionnaire

    At inclusion

  • DTSQs questionnaire

    At inclusion

  • +1 more secondary outcomes

Study Arms (1)

Adults with type 1 diabetes mellitus using AID and engaging in regular physical activity

Other: No Intervention: Observational Cohort

Interventions

No intervention

Adults with type 1 diabetes mellitus using AID and engaging in regular physical activity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be recruited by four specialized tertiary diabetes care centers (Vandœuvre-lès-Nancy, Strasbourg, Caen, and Mainvilliers).

You may qualify if:

  • Adult participants with diabetes mellitus type 1
  • User for at least 3 months of one the three automated insulin delivery systems available in France at the time of the study (Minimed 780G pump + Guardian 4 sensor + PID-IFB algorithm; or T:Slim X2 pump + Dexcom G6 sensor + Control-IQ algorithm; or mylife Ypsopump + Dexcom G6 sensor + CamAPS FX app)
  • Engaged in regular physical activity as part of daily life (at least 2 structured sessions per week, each lasting more than 30 minutes)
  • Able to download data from the pump
  • Willing and able to complete the physical activity log and self-questionnaires in French
  • Having received the information sheet and given their oral consent (non-opposition) to participate in the study and for their data processing

You may not qualify if:

  • Participants currently enrolled in a clinical trial
  • Pregnancy or breastfeeding women or women planning a pregnancy during the study
  • Adults under legal protection (guardianship, curatorship, or judicial safeguard)
  • Participants with decompensated retinopathy
  • Participants with decompensated cardiac disease
  • History of severe hypoglycemia during physical activity in the past 6 months
  • Participants with unresolved diabetic foot trophic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

CHU of Caen

Caen, 14033, France

Location

Institute of Diabetology

Mainvilliers, 28300, France

Location

CHRU of Nancy

Nancy, 54511, France

Location

University Hospitals of Strasbourg

Strasbourg, 67091, France

Location

Related Publications (1)

  • Joubert M, Meyer L, Bekka S, Rakotoarisoa L, Scheyer N, Dreves B, Guerci B. Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study. Diabetes Obes Metab. 2025 Dec;27(12):7221-7231. doi: 10.1111/dom.70122. Epub 2025 Sep 9.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Glucose Metabolism DisordersHypoglycemia

Condition Hierarchy (Ancestors)

Diabetes MellitusMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Bruno GUERCI, Professor, MD, PhD

    CHRU Nancy and University of Lorraine, Nancy, france

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2025

First Posted

June 11, 2025

Study Start

March 5, 2024

Primary Completion

December 15, 2024

Study Completion

December 15, 2024

Last Updated

January 26, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

In accordance with the General Data Protection Regulation and French data protection law, the presentation of the results derived from data processing shall under no circumstances allow the direct or indirect identification of individuals participating in the research. In the event of publication of the research findings in a scientific journal, access to the data by an independent expert - including one appointed by a scientific publisher - shall only be granted through the interface provided or designated by the Data Controller, solely for the purpose of verifying or reproducing the analyses, and exclusively under the conditions defined for secure consultation and data handling.

Locations